<原著>複合内分泌療法のラットDMBA誘発乳癌に対する抗腫瘍効果と内分泌動態
スポンサーリンク
概要
- 論文の詳細を見る
Antitumor effects of combined hormonal therapy was investigated on DMBA-induced rat mammary carcinomas. The hormonal agents and their daily doses were 0.5 mg/kg for aromatase inhibitor, CGS 16949A (CGS), 16 mg/kg for medroxyprogesterone acetate (MPA) and 0.4 mg/kg for antiestrogen, tamoxifen (TAM). These agents were administered for three weeks continuously. CGS was combined with MPA and TAM for comparison with these single administrations. Tumor size compared to the non-treated control taken as 100% was 34.5% in the CGS+TAM group, 55.3% in the TAM group, 57.6% in the MPA group and 58.2% in the CGS group. However, there was no significant antitumor effect in the CGS+MPA group i. e., 84.3%. This was supposed to be related to the change in estrogen receptor contents had been changed to negative in 66.7% in the CGS+TAM group after treatment, while no case showed any change in estrogen receptor contents in the CGS+MPA group. There was no great difference in level of blood estradiol between the CGS+TAM (3.5±0.5pg/ml) and the CGS+MPA group (3.2±0.2pg/ml). On the other hand, the level of blood prolactin was higher in the CGS+TAM group (14.8±3.1ng/ml) than the CGS+MPA group (3.4±0.4ng/ml). This indicates that rat mammary tumors should be more sensitive for estrogen than prolactin. In histological findings, clear atrophic change of tubular formation in the CGS+TAM group and slight atrophic change of tubular formation in the CGS+MPA group were observed. However, in the CGS+MPA group, the destruction of cell and necrosis frequently noted in the MPA alone group was not detected. When CGS and TAM were administered the same time, the antitumor effect was higher than when they were administered alone. However, the combination of CGS and MPA reduced the antitumor effect in spite of the significant decrease in the level of blood estradiol. These findings indicate that the level of estradiol in the cancer tissue is a more important factor than the level of blood for tumor growth in DMBA induced rat mammary tumors.
- 近畿大学の論文
- 1992-03-25
著者
関連論文
- 428 IIc 型早期大腸癌の2例(第31回日本消化器外科学会総会)
- 三病巣の胃癌と悪性リンパ腫の同時性四重複癌の1例
- 14歳女児に認められた甲状腺乳頭癌
- ラット7,12-dimethylbenz(a)anthracene誘発乳癌におけるestramustine phosphateの抗腫瘍効果の検討
- 第53回日本肺癌学会関西支部会 : 38.当科における転移性肺癌の外科治療成績
- P-240 Collagen Gel包埋培養法による制癌剤感受性試験における接触条件の検討
- 16.乳癌骨転移の早期発見の試み
- 28.乳癌細胞に対する内分泌化学療法の影響に関する研究 : とくにDMBA乳癌における核DNA量の変化について
- 12.乳房温存手術の局所再発例の検討 : 特に温存手術適応例の検討
- 複合内分泌療法のラットDMBA誘発乳癌に対する抗腫瘍効果と内分泌動態
- 進行乳癌の治療におけるchemo-endocrine therapyの意義
- 226 術後短期間の血漿 CEA 値推移と laminin 染色性からみた大腸癌肝転移再発の危険率予測(第31回日本消化器外科学会総会)